Search results
Texas Company’s Mission to Cure Macular Degeneration Blindness
The Sacramento Bee· 6 days agoTwenty Million people in America (12% of the population over 40) have Macular Degeneration...
AlayaCare Selected by ParaMed as Technology Platform to Power Home Health Care Across Canada
Digital Journal· 6 days agoLife Insurance Trust (ILIT) Using Travel Rewards to Stay in 5-Star Hotels Texas Company's Mission to Cure Macular Degeneration Blindness ...
Emmecell Completes Final Cell Therapy Dosing in U.S. Clinical Trial for Corneal Edema
Digital Journal· 6 days agoEmmecell has a broad intellectual property (IP) portfolio and is focusing its initial efforts on ophthalmic indications, including corneal edema and macular degeneration ...
Nanoscope Therapeutics to Present at the OIS and Retinal Cell and Gene Therapy Innovation Summits
WJET - WFXP Erie· 7 days agoNanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for retinal degenerative diseases, today announced that Samarendra Mohanty, PhD, Co-Founder ...
WiBotic – the Leader in Advanced Wireless Charging Solutions for Mobile Robots – Unveils One...
Digital Journal· 6 days agoThe newest, fastest-growing and most disruptive newswire available today. More from ACCESSWIRE Texas Company's Mission to Cure Macular Degeneration ...
Ovaterra’s New Advanced Prenatal Vitamins Formula Leverages the Latest Science to Meet the...
Digital Journal· 6 days agoLife Insurance Trust (ILIT) Using Travel Rewards to Stay in 5-Star Hotels Texas Company's Mission to Cure Macular Degeneration Blindness ...
Windings Inc. Strengthens Board with New Strategic Director Appointments
Digital Journal· 6 days agoLife Insurance Trust (ILIT) Using Travel Rewards to Stay in 5-Star Hotels Texas Company's Mission to Cure Macular Degeneration Blindness ...
Hoverfly Technologies: Leading the Charge with American-Made Tethered Drones
Digital Journal· 6 days agoLife Insurance Trust (ILIT) Using Travel Rewards to Stay in 5-Star Hotels Texas Company's Mission to Cure Macular Degeneration Blindness ...
Nanoscope Therapeutics Announces Presentations at the ARVO Annual Meeting
CBS 47 Fresno· 4 days agoNanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for retinal degenerative diseases, today announced that its Multi-Characteristic Opsin (MCO ...
Johnson & Johnson Highlights Commitment to Transform Treatment of Retinal Diseases at ARVO 2024
Char-Koosta News· 3 days agoCompany to present, across eight data presentations, new real-world research on the economic value...